CN Stock MarketDetailed Quotes

Hangzhou Alltest Biotech (688606)

Watchlist
  • 54.84
  • -0.74-1.33%
Market Closed May 14 15:00 CST
4.35BMarket Cap24.37P/E (TTM)

Hangzhou Alltest Biotech (688606) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
传染病类359.08M39.66%
毒品及药物滥用类287.23M31.73%
Other classes107.53M11.88%
妇女健康类86.18M9.52%
Tumor class23.48M2.59%
心肌类18.82M2.08%
新冠检测类17.12M1.89%
Other business5.9M0.65%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
In vitro diagnosis industry899.45M99.35%
Other business5.9M0.65%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Abroad836.44M92.39%
Domestic63.01M6.96%
Other business5.9M0.65%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More